These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Ganzini L; Heintz RT; Hoffman WF; Casey DE Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743 [TBL] [Abstract][Full Text] [Related]
24. Tardive dyskinesia and depressive illness. Davis KL; Berger PA; Hollister LE Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603 [TBL] [Abstract][Full Text] [Related]
25. Spontaneous and tardive dyskinesias: clinical and laboratory studies. Casey DE J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480 [TBL] [Abstract][Full Text] [Related]
26. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series. Patra S Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425 [TBL] [Abstract][Full Text] [Related]
28. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Tan EC; Chong SA; Mahendran R; Dong F; Tan CH Biol Psychiatry; 2001 Jul; 50(2):144-7. PubMed ID: 11526996 [TBL] [Abstract][Full Text] [Related]
29. Distinguishing akathisia and tardive dyskinesia: a review of the literature. Munetz MR; Cornes CL J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392 [TBL] [Abstract][Full Text] [Related]
30. CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs. Benjamin S; Munetz MR Hosp Community Psychiatry; 1994 Apr; 45(4):343-6. PubMed ID: 7912689 [TBL] [Abstract][Full Text] [Related]
34. [Improvement of tardive dyskinesia after treatment with olanzapine]. Truöl S; Von Hippel C; Raape J; König F Psychiatr Prax; 2002 Sep; 29(6):315-7. PubMed ID: 12224042 [TBL] [Abstract][Full Text] [Related]